Compare KIDZW & IXHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | KIDZW | IXHL |
|---|---|---|
| Founded | N/A | 2001 |
| Country | United States | Australia |
| Employees | N/A | N/A |
| Industry | | |
| Sector | | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | N/A | 49.1M |
| IPO Year | N/A | N/A |
| Metric | KIDZW | IXHL |
|---|---|---|
| Price | $0.02 | $0.43 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | N/A | ★ 24.8M |
| Earning Date | N/A | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $12,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | N/A | $0.08 |
| 52 Week High | N/A | $2.25 |
| Indicator | KIDZW | IXHL |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 57.22 |
| Support Level | N/A | $0.38 |
| Resistance Level | N/A | $0.50 |
| Average True Range (ATR) | 0.00 | 0.04 |
| MACD | 0.00 | 0.01 |
| Stochastic Oscillator | 0.00 | 63.35 |
Classover Holdings Inc is an education technology company based in New York. It provides comprehensive online interactive live courses for K-12 students in the United States and around the globe. Its curriculum is designed to meet the needs of different age groups and learning levels, covering various subjects to enhance students' academic achievements and interest in exploration. The company offers both interest-oriented classes and test preparation courses for various exams and competitions. With its approach, Classover aims to transcend the boundaries of traditional education by offering students a comprehensive set of lifelong skills and capabilities, including creativity, critical thinking, and problem-solving, in an engaging and interactive environment.
Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.